蛋白质药物载体设计的有效策略,以深入了解蛋白质-多电解质相互作用
Yi-Zhen Wan1, Ning Ma1, Yu Zhang1
1State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, People's Republic of China.
Langmuir : the ACS journal of surfaces and colloids
|January 2, 2025
概括
这项研究引入了一种结合有序多孔层干涉测量 (OPLI) 和电泳光散射 (ELS) 的新方法,以优化基于多电解质的蛋白质药物载体. 这些发现揭示了表面电荷和pH值如何影响蛋白质吸附,提高药物加载效率.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 基于多电解质的蛋白载体在药物开发中至关重要.
- 传统方法缺乏对载体制造和蛋白质加载动态的洞察力.
- 需要对多电解质-蛋白质相互作用有全面的了解.
研究的目的:
- 开发和验证OPLI和ELS联合策略,用于研究多电解质-蛋白相互作用.
- 在载体制造和蛋白质加载过程中研究聚电解质-蛋白质相互作用的机制.
- 为了优化基于多电解质的药物载体的蛋白质加载效率.
主要方法:
- 采用层层组装,在合体晶体 (SCC) 薄膜和纳米球上创建多电解质复合物 (PEC) 层.
- 雇员订购的多孔层干扰测量 (OPLI) 用于实时分析SCC膜上的PEC蛋白相互作用.
- 应用电泳光散射 (ELS) 来测量z-潜在的机械洞察力和电荷验证.
主要成果:
- 证明受pH值和多电解质层数量影响的表面电荷会影响静电吸附.
- 显示了蛋白质吸附的显著增加,PEC层和蛋白质之间的z-电位差异更大.
- 确定在蛋白质加载过程中调整pH值可以最大限度地提高加载效率.
结论:
- 结合的OPLI和ELS方法为开发先进的基于聚电解质的蛋白质药物载体提供了有效的策略.
- 这种方法允许在现场接口研究转移到分散的纳米粒子系统.
- 优化pH值和了解电荷动态是最大限度地提高蛋白质药物载体效率的关键.
相关概念视频
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein-Drug Binding: Determination Methods
117
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
117
Protein-Drug Binding: Mechanism and Kinetics
278
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
278
Pore Transport and Ion-Pair Transport
350
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
350
Factors Affecting Protein-Drug Binding: Drug-Related Factors
78
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
78
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K


